Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy. [electronic resource]
Producer: 20180409Description: 818-821 p. digitalISSN:- 1346-8138
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- Biopsy
- CTLA-4 Antigen -- antagonists & inhibitors
- Chemotherapy, Adjuvant -- adverse effects
- Drug Eruptions -- diagnosis
- Drug Resistance
- Erythema Multiforme -- chemically induced
- Fever -- chemically induced
- Glucocorticoids -- pharmacology
- Humans
- Indoles -- therapeutic use
- Ipilimumab
- Lung Diseases, Interstitial -- drug therapy
- Lymphatic Metastasis
- Male
- Melanoma -- genetics
- Mutation
- Neoplasm Recurrence, Local -- pathology
- Nivolumab
- Parotid Neoplasms -- drug therapy
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Pulse Therapy, Drug
- Skin Neoplasms -- genetics
- Sulfonamides -- therapeutic use
- Tomography, X-Ray Computed
- Trimethoprim, Sulfamethoxazole Drug Combination -- therapeutic use
- Vemurafenib
- Withholding Treatment
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.